Elastic Young’s modulus of ER+ cancer cells in different tamoxifen concentrations and HER2+ cancer cells post-treatment with trastuzumab, pertuzumab, and their synergistic effect in even concentrations. The gene discussed is ERBB2; the disease is cancer.